Dermatology Times, April 2021 (Vol. 42, No. 4)

Combination Foam May Benefit Patients of Color

May 03, 2021

Study findings show calcipotriene-betamethasone foam to be safe and moderately effective in skin of color patients with psoriasis but failed to meet several secondary endpoints and to demonstrate statistically significant changes.

Microneedling Strategies

April 27, 2021

Microneedling with or without radiofrequency energy has become a very popular cosmetic procedure. Understanding the science behind these versatile devices can help clinicians better harness their therapeutic potential and ensure positive treatment outcomes in their patients.

Neuromodulators Combat Key Rosacea Challenges

April 22, 2021

In treatments addressing muscular contraction, botulinum toxin inhibits nerves that innervate blood vessels from releasing acetylcholine, which triggers vasodilation. Its impact on the innate immune system suggests that botulinum toxin may also help reduce recalcitrant rosacea-related papules and pustules.

Emerging Agents Augment Melasma Modalities

April 09, 2021

An array of agents for blocking visible light and lightening skin are joining the armamentarium to treat melasma. Despite this expanding number of therapeutic interventions, melasma is a chronic, therapeutically challenging disease for which there is no cure, so treatment plans should address both management of the disease and patient expectations.

Vaccine Patients Experiencing ‘Vaccine Arm’ Days After Injection

March 19, 2021

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose. Experts assure that while the delayed side effect is uncomfortable, it is temporary and can be treated at home.

Ruxolitinib Cream NDA Accepted for Priority Review by FDA

March 12, 2021

Incyte announces the FDA has accepted the NDA for ruxolitinib cream for priority review. Ruxolitinib cream is a topical selective janus kinase (JAK)1/JAK2 inhibitor intended for the treatment of atopic dermatitis.